0001209191-23-053004.txt : 20231017 0001209191-23-053004.hdr.sgml : 20231017 20231017184059 ACCESSION NUMBER: 0001209191-23-053004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231016 FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gupta Rishi CENTRAL INDEX KEY: 0001537370 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231330587 MAIL ADDRESS: STREET 1: C/O CHEMOCENTRYX, INC. STREET 2: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Turnstone Biologics Corp. CENTRAL INDEX KEY: 0001764974 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832909368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 347-897-5988 MAIL ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-16 0 0001764974 Turnstone Biologics Corp. TSBX 0001537370 Gupta Rishi C/O TURNSTONE BIOLOGICS CORP. 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 1 0 1 0 0 Stock Option (Right to Buy) 2.61 2023-10-16 4 A 0 25540 0.00 A 2033-10-15 Common Stock 25540 25540 D Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the date of the first annual general meeting of stockholders occurring after October 12, 2023, subject to the Reporting Person's continuous service through each such vesting date. Pursuant to an agreement between OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefits thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP. /s/ P. Joseph Campisi, Jr., Attorney-in-Fact 2023-10-17